Compare DG & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DG | STE |
|---|---|---|
| Founded | 1939 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Department/Specialty Retail Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 24.4B |
| IPO Year | 2008 | 2018 |
| Metric | DG | STE |
|---|---|---|
| Price | $152.51 | $248.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 6 |
| Target Price | $136.81 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 2.4M | 980.0K |
| Earning Date | 03-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.51% | 1.00% |
| EPS Growth | N/A | ★ 62.73 |
| EPS | 4.92 | ★ 5.69 |
| Revenue | ★ $40,612,308,000.00 | $5,459,515,000.00 |
| Revenue This Year | $8.03 | $9.84 |
| Revenue Next Year | $4.19 | $6.34 |
| P/E Ratio | ★ $31.63 | $44.38 |
| Revenue Growth | 4.96 | ★ 6.24 |
| 52 Week Low | $70.01 | $204.90 |
| 52 Week High | $158.23 | $269.44 |
| Indicator | DG | STE |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 45.72 |
| Support Level | $142.16 | $239.76 |
| Resistance Level | $153.42 | $253.95 |
| Average True Range (ATR) | 4.56 | 5.13 |
| MACD | -0.00 | 0.57 |
| Stochastic Oscillator | 58.94 | 61.55 |
Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated $40 billion in fiscal 2024 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.